calendar
2,424 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 108 grant
2,424 catalysts · 3,921 phase readout · 2,141 8k filing · 277 earnings · 172 phase 2 completion · 133 drug shortage · 108 grant
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 8.01, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02
Items: 5.07
Items: 5.03, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 3.02, 9.01
Items: 8.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 7.01, 8.01, 9.01
Items: 2.03, 3.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 5.02, 8.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 1.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 7.01, 9.01
Anticipated earnings call for LB PHARMACEUTICALS INC ($LBRX).
Anticipated earnings call for ArriVent BioPharma, Inc. ($AVBP).
Anticipated earnings call for Allogene Therapeutics, Inc. ($ALLO).
Anticipated earnings call for NEONC TECHNOLOGIES HOLDINGS, INC. ($NTHI).
Anticipated earnings call for ALUMIS INC. ($ALMS).
Items: 5.07
Items: 7.01, 8.01
Items: 2.02, 7.01, 9.01
Items: 5.03, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01